Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 44

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 44
---
rogated in such manner
(if any) as may be provided by those rights or (in the absence of any such provision) either with the consent in writing of the holders
of at least 75% of the issued shares of that class or with the authority of a special resolution passed at a separate general meeting
of the holders of the shares of that class.

Alteration of Share Capital and Repurchases

Subject to the provisions
of the Companies Act, and without prejudice to any relevant special rights attached to any class of shares, we may by ordinary resolution,
from time to time:

| · | increase our share capital by allotting and issuing new shares in accordance with our articles of association and any relevant shareholder resolution; |

| · | consolidate all or any of our share capital into shares of a larger nominal amount (i.e., par value) than the existing shares; |

| · | subdivide any of our shares into shares of a smaller nominal amount (i.e., par value) than our existing shares; or |

| · | redenominate our share capital or any class of share capital. |

Preemptive Rights and New Issuance of Shares

Under the Companies Act, the
issuance of equity securities (except shares held under an employees’ share scheme) that are to be paid for wholly in cash must
be offered first to the existing holders of equity securities in proportion to the respective nominal amounts (i.e., par values) of their
holdings on the same or more favorable terms, unless a special resolution to the contrary has been passed or the articles of association
otherwise provide an exclusion from this requirement (which exclusion can be for a maximum of five years after which our shareholders’
approval would be required to renew the exclusion). In this context, “equity securities” means ordinary shares (and would
exclude shares that, with respect to dividends or capital, carry a right to participate only up to a specified amount in a distribution),
and any and all rights to subscribe for or convert securities into such ordinary shares. This differs from U.S. law, under which shareholders
generally do not have pre-emptive rights unless specifically granted in the certificate of incorporation or otherwise.

The Board of Directors seek
general authority to allot shares on a non-pre-emptive basis at each annual general meeting. Preemptive rights under the Companies Act
will not apply in respect of allotment of shares for cash made pursuant to such authority.

Transfer of Shares

Any certificated shareholder